Duality Advisers, LP Halozyme Therapeutics, Inc. Transaction History

Duality Advisers, LP

$0
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$33.68 - $41.95 $903,701 - $1.13 Million	-26,832 Reduced 50.7%	26,094 $1.06 Million
Q4 2023 Feb 01, 2024	BUY	$33.32 - $42.1 $417,199 - $527,134	12,521 Added 30.99%	52,926 $1.96 Million
Q3 2023 Nov 02, 2023	BUY	$36.46 - $44.03 $912,265 - $1.1 Million	25,021 Added 162.64%	40,405 $1.54 Million
Q2 2023 Jul 31, 2023	SELL	$30.28 - $38.74 $1.63 Million - $2.09 Million	-53,909 Reduced 77.8%	15,384 $554,000
Q1 2023 Jun 27, 2023	BUY	$32.86 - $55.7 $1.05 Million - $1.77 Million	31,807 Added 84.85%	69,293 $2.65 Million
Q4 2022 Feb 07, 2023	BUY	$40.06 - $59.44 $1.5 Million - $2.23 Million	37,486 New	37,486 $2.13 Million
Q2 2022 Aug 08, 2022	SELL	$37.35 - $48.3 $452,420 - $585,057	-12,113 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$31.97 - $41.06 $387,252 - $497,359	12,113 New	12,113 $483,000
Q4 2021 Feb 02, 2022	SELL	$31.82 - $40.75 $2.89 Million - $3.7 Million	-90,705 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$38.47 - $46.42 $3.49 Million - $4.21 Million	90,705 New	90,705 $3.69 Million
Q2 2021 Aug 09, 2021	SELL	$38.84 - $51.31 $773,187 - $1.02 Million	-19,907 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$39.51 - $51.45 $786,525 - $1.02 Million	19,907 New	19,907 $830,000
Q4 2020 Feb 09, 2021	SELL	$25.81 - $43.62 $1.05 Million - $1.77 Million	-40,490 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$25.74 - $29.63 $190,784 - $219,617	7,412 Added 22.41%	40,490 $1.06 Million
Q2 2020 Jul 29, 2020	BUY	$16.25 - $26.81 $537,517 - $886,821	33,078 New	33,078 $886,000
Q1 2020 May 06, 2020	SELL	$13.9 - $21.83 $310,456 - $487,573	-22,335 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$14.93 - $19.53 $333,461 - $436,202	22,335 New	22,335 $396,000

Others Institutions Holding HALO

# of Institutions

543

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

Black Rock Inc. New York, NY

17.6M
Shares

$838 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

12.9M
Shares

$613 Million
0.01% of portfolio
State Street Corp Boston, MA

6.63M
Shares

$315 Million
0.02% of portfolio
Snyder Capital Management L P San Francisco, CA

4.06M
Shares

$193 Million
5.07% of portfolio
Alliancebernstein L.P. New York, NY

3.41M
Shares

$162 Million
0.07% of portfolio

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Duality Advisers, LP with notifications on news.

Account